Stockreport

MindMed to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025

Mind Medicine (MindMed) Inc. - Common Shares  (MNMD) 
PDF NEW YORK--(BUSINESS WIRE)--Mind Medicine (MindMed) Inc. (Nasdaq: MNMD), (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing nove [Read more]